Get started today

Case Study: Dementia

Presented by Dr Philip Blair, MD

About this module:

In this presentation, Dr Philip Blair MD presents a case study in dementia, including his treatment protocol using cannabinoid therapy. The mechanisms of action of CBD in modulating the endocannabinoid system and how CBD may work in addressing the pathogenesis of dementia is discussed and general treatment guidelines discussed.

This presentation is targeted at clinicians and assumes a knowledge of the endocannabinoid system and pharmacodynamics of the components of medicinal cannabis. 
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe the various pathways of disease involved in dementia.
  • Describe how CBD can modulate the endocannabinoid system.
  • Describe the metabolic effects of CBD and its role in modulating the immune system.  
  • Explain the potential mechanisms of action of cannabidiol (CBD) in addressing the pathogenesis of dementia.
  • Formulate a treatment strategy for the use of CBD in dementia.

Dr Philip Blair, MD

Dr. Philip Blair, MD, (Colonel, US Army, retired) is a Family Physician and consultant in disease management in the Northwest USA. He graduated from West Point in 1972, attended the University of Miami School of Medicine, training as an Army Family Physician and serving as a combat physician in the first Gulf War. After medical assignments in three continents and 29 years in uniform, he retired from the Army and has been consulting on complex disease management since 2000.

Dr. Blair has been studying, treating, and lecturing about the human body’s natural endocannabinoid system (ECS) since 2014. His goal is to restore health and performance by enhancing the ECS using diet, exercise, appropriate medications and non-psychoactive therapies.
Created with